FDA, DOH Reiterate Insufficient Evidence To Support Efficacy, Safety Of Ivermectin For COVID-19
The FDA and the DOH reiterated the insufficient evidence to support the efficacy and safety of Ivermectin for COVID-19. The Food and Drug Administration (FDA) and the Department of Health (DOH) reiterated the insufficient evidence to support the efficacy and safety of Ivermectin for COVID-19. In a report on Manila Bulletin, the Food and Drug … Read more